Tag: DARA BioSciencesSort
GRVY, CRWE, AONE, DARA - PennyOtcStock.com Stock Report! GRAVITY Co. Ltd., Crown Equity Holdings Inc., A123 Systems, DARA BioSci
DARA, CLNO, ODC, JBL, TK - Market Watch From BestOtc.com!
DARA BioSciences, Inc. (Nasdaq:DARA) announced that five new patents were granted in the United States, Asia and Israel for its drug development programs, including lead drug candidates KRN5500 and DB959. These grants represent a total gain of 20 new U.S. and foreign patents in 2011.
(DARA, POWR, ERII, CLNO, ENTR) Stocks in Action by StockHotTips.com
DARA BioSciences, Inc. (Nasdaq:DARA) is a clinical stage pharmaceutical development company that acquires high quality, promising therapeutic molecules in early stage development (late pre-clinical or Phase 1). Acquired molecules have the potential to fill significant medical needs and represent large commercial opportunities for participation in large and growing markets.
(DARA, MKTG, SLXP) PennyOmega.com Watch List for Wed Nov. 09, 2011
SLXP, Salix Pharmaceuticals, Ltd.
** On its third quarter fiscal 2011 results, SLXP posted total product revenue of $146.2 million, an 81% increase year over year.
SLXP is increasing its estimate of 2011 total product revenue to approximately $535 million, which represents 59% growth over 2010 revenue.
(MJGCF.PK, TST, IFON, DARA) Stocks in Focus by CRWESelect.com
MAJESTIC GOLD CORP (MJGCF.PK)
MAJESTIC GOLD CORP (MJGCF.PK) engages in the exploration and development of mineral properties in China. The company focuses on its gold project located in the prolific gold region of Song Jiagou in eastern Shandong Province. Majestic Gold Corp. is headquartered in Vancouver, Canada.
(DARA,RDNT, BBND, HTGC) Stocks Report by stock-pr.com
LIMA, FORC, SCD, DARA, TLI - Stock Market Report by CRWESelect.com
ARLP, FORC, TGC, DARA, PRTS - Stock-PR.com Presents Evening Stock Market Highlights and News!!
DARA BioSciences reported today that SurgiVision, Inc., a privately held company, and Brainlab AG, announced on April 11 a collaboration aimed at integrating SurgiVision’s ClearPoint(R) product line with Brainlab’s iMRI product line, with particular focus on local delivery of drugs and other therapeutic agents to precision targets in the brain under magnetic resonance imaging (MRI) guidance.